Feedback / Questions
CK0804 - Cellenkos, Incyte
Jakafi (ruxolitinib) - Novartis, Incyte
https://www.newswire.ca/news-releases/cellenkos-receives-fda-clearance-of-investigational-new-drug-ind-application-for-ck0804-as-add-on-therapy-to-ruxolitinib-for-the-treatment-of-myelofibrosis-827933251.html
Jun 14, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next